Integrating Academic Laboratories Into Pharmaceutical Development
暂无分享，去创建一个
Historically, there has been somewhat of an arm's-length relationship between researchers in academic medical centers and pharmaceutical companies. However, this attitude has undergone a major change over the past three decades and academicians have taken an entrepreneurial approach through the formation of biotech firms. This article discusses the history and development of strong ties between academic scientists and the pharmaceutical industry, including potential pitfalls associated with this association.
Keywords:
pharmaceutical companies;
academicians;
scientists;
biotech companies;
research collaborations
[1] Debashis Ghosh,et al. Autoantibody signatures in prostate cancer. , 2005, The New England journal of medicine.
[2] Kozlowski. Industrial-academic collaboration: a bridge too far? , 1999, Drug discovery today.
[3] S. Dhanasekaran,et al. Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer , 2007, Nature.
[4] S. Dhanasekaran,et al. The polycomb group protein EZH2 is involved in progression of prostate cancer , 2002, Nature.